Any CEO with a track record of the past two years would have been replaced ! We "get it" no other choice then toxic funding but let's look how we got here. Management should be compensated based on performance including "titles". Imo GNBT is on the back burner and I think no priority to take public due to pps and total outstanding shares !! How about rev estimates, valuation and 10k filing!! Even if we start having results it's hard to trust current Management with funds and start allover!! Unfortunately the Board is controlled by a few friendly shares . I believe we may have a chance with the scientific group but if no vaccine, BARDA or FDA approval get ready for more "exciting" times. We need experienced/credible management to attract institutional support, positive analyst coverage and new investors ! Pretty soon we will be talking about a reverse split .............